Molecular Targeting Technologies, Inc. Licenses Robust Near-infrared (NIR) Dye Technology from the Massachusetts General Hospital/Harvard Medical School

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc., (MTTI) announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.